MedTrace Logo

Betamethasone and Complications of Lower Third Molar Surgery

NCT07297264 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-12-22

No results posted yet for this study

Summary

Pain, swelling, and trismus are common sequalae of surgical removal of impacted third molars. The aim of this study is to evaluate effect of local administration of betamethasone, into the pterygomandibular space, on these sequalae

Conditions

  • Morbidity
  • Third Molars Extraction
  • Steroid Injection

Interventions

DRUG

Betamethasone

The study group (group I) received 1 ml (6 mg) of betamethasone (CKOÇAK FARMA, Turkey) injection to the pterygomandibular space. Each ml contains 3.0 mg betamethasone acetate and 3.0 mg betamethasone sodium phosphate

DRUG

normal saline

normal saline

Sponsors & Collaborators

  • Shehab Ahmed Hamad

    lead OTHER

Principal Investigators

  • Shehab Hamad, FFDRCSI · Kurdistan Higher Council of Medical Specialties

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2023-02-21
Completion
2023-03-26

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07297264 on ClinicalTrials.gov